Christopher M. Barlow

Christopher M. Barlow

Partner, Mergers and Acquisitions; Private Equity
Christopher M. Barlow focuses on mergers and acquisitions, corporate governance, private equity, special purpose acquisition companies (SPACs), securities and general corporate law matters.


Mr. Barlow regularly advises public and private companies, private equity firms and financial institutions in a variety of corporate matters, including acquisitions, divestitures, restructurings, financial advisor engagements, financings, leveraged buyouts, shareholder activism and takeover preparedness. Examples of his representations include:

  • Social Capital Hedosophia in its:
    • pending $3.7 billion merger with Clover Health Investments Corp.;
    • $4.8 billion merger with Opendoor Labs; and
    • $1.5 billion merger with Virgin Galactic;
  • Permira Funds in numerous transactions, including in:
    • its $4.2 billion sale of a majority stake in Duff & Phelps; 
    • its $2.4 billion acquisition of Cambrex Corporation;
    • its acquisition of a majority stake in Reformation;
    • the $1.9 billion sale of an 80 percent stake in its portfolio company Netafim Ltd. to Mexichem, S.A.B. de C.V.;
    • the sale of a majority stake in Teraco Data Environment to Berkshire Partners;
    • its acquisition of a majority stake in Cielo, Inc. from Accel-KKR; and
    • its acquisition of Evonik Jayhawk Fine Chemicals Corporation from Evonik Industries AG;
  • Spotify in its acquisitions of:
    • Megaphone from Graham Holdings (pending);
    • Bill Simmons’ The Ringer;
    • Gimlet Media Inc.;
    • Anchor FM Inc.;
    • Cutler Media, LLC;
    • SoundBetter;
    • The Echo Nest; and
  • Kemet Corp. in its pending $1.8 billion acquisition by Yageo Corp.;
  • NXP Semiconductors N.V. in its proposed but terminated acquisition by Qualcomm Inc.;
  • Wenner Media LLC in numerous transactions and corporate matters, including:
    • a strategic investment in Wenner Media LLC from Penske Media Corporation;
    • its sale of US Weekly to American Media, Inc.; and
    • its sale of a 49 percent stake in Rolling Stone Magazine;
  • Kelso & Co. in its acquisition of Physicians Endoscopy, LLC in a recapitalization transaction with management from Pamlico Capital;
  • Anbang Insurance Group Co., Ltd. as lead member of an investor group in its proposed, unsolicited $14 billion acquisition of Starwood Hotels & Resorts Worldwide Inc., which would have been the largest acquisition of a U.S. company by a Chinese buyer if completed;
  • Pinnacle Entertainment in connection with the unsolicited offer by Gaming & Leisure Properties Inc. and subsequent merger with GLPI following a spin-off of Pinnacle’s operating business;
  • Frontier Communications Corporation in its $10.5 billion acquisition of the wireline businesses of Verizon in California, Texas and Florida;
  • Integrated Whale Media Investments, a Hong Kong-based investor group, in its acquisition of a majority stake in Forbes Media LLC;
  • Cobham plc in its $1.46 billion acquisition of Aeroflex Holding Corp.;
  • BlackBerry Ltd. in its exploration of strategic alternatives, culminating in a $1 billion private placement of convertible debentures;
  • Gardner Denver, Inc. in its $3.9 billion acquisition by Kohlberg Kravis Roberts & Co. L.P.;
  • Valeant Pharmaceuticals International, Inc. in multiple transactions and corporate matters, including its:
    • $8.7 billion acquisition of Bausch + Lomb Holdings Incorporated from Warburg Pincus LLC; and
    • acquisition of OraPharma Inc. from Water Street Healthcare Partners;
  • Dean Foods Company in its $1.45 billion sale of its Morningstar Foods division to Saputo Inc.; Transocean Limited in its proxy contest with Carl Icahn;
  • EverBank Financial Corp. in its 2012 initial public offering;
  • IAC’s in its minority investment in Zhenai Inc.; and
  • financial advisors, including:
    • Goldman Sachs & Co. LLC and Centerview Partners LLC in Momenta Pharmaceuticals, Inc.’s $6.5 billion pending sale to Johnson & Johnson;
    • Centerview Partners LLC in Portola Pharmaceuticals, Inc.’s $1.4 billion sale to Alexion Pharmaceuticals, Inc.;
    • J.P. Morgan Securities LLC in WebMD Health Corp.’s $2.8 billion sale to Internet Brands, a KKR portfolio company;
    • Goldman, Sachs & Co. in Emergency Medical Services Corporation’s $3.2 billion sale to Clayton, Dubilier & Rice, LLC; and
    • Guggenheim Securities, LLC in West Marine, Inc.’s $338 million sale to Monomoy Capital Partners.

Mr. Barlow also has provided pro bono legal services to a variety of New York-based clients.



  • J.D., Boston University School of Law, 2009 (cum laude; Review of Banking and Financial Law)
  • M.A., State University of New York, Buffalo, 2005
  • B.A., University of Wisconsin, Green Bay, 2003 (magna cum laude)


  • New York

Christopher M. Barlow

Partner, Mergers and Acquisitions; Private Equity